FDA Drug Application (202776) for MONTELUKAST SODIUM by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202776
Product Number001
FormGRANULE;ORAL
DosageEQ 4MG BASE/PACKET
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMONTELUKAST SODIUM
Active IngredientMONTELUKAST SODIUM

Active IngredientCount
List of drugs with Active Ingredient MONTELUKAST SODIUM2


Back to FDA Applications sponsored by MYLAN PHARMS INC